Please login to the form below
The Editors blog
An inside look at what’s happening within the pharma industry and across the PMGroup from the PMLiVE editorial team
Jeux sans frontières
Can NICE deliver on its funding promises?10 Mar 2017
The Institute is now half-way thorugh its Cancer Drugs Fund reappraisals
Brexit: Bad for health, science and pharma15 Jun 2016
Health care voices join the life sciences sector in warning of the negative impact of leaving the EU
Finalists revealed for Communiqué Awards 201609 Jun 2016
Forty-three agencies in the running for one of the prestigious prizes
GSK and Novartis asset swap: a tale of two companies13 Mar 2015
Firms complete multi-billion dollar exchange ofoncology, vaccines and consumer health interests
2014: a year to build pharma's reputation02 Jul 2014
Recent megamerger prospects have led to a backlash in the mainstream media
Burden of proof06 Jun 2014
Breakthroughs in Alzheimer's are sorely needed, but there's still lots of work to do on AD04
A sharper focus16 May 2014
The enthusiasm for massive M&A deals is set to redraw industry boundaries
-
Open season?
17 Feb 2014
The EMA's decision to post minutes of CHMP meetings is another step forward for industry transparency
Resistance's irresistible need14 Jan 2014
Industry's anti-infective efforts step up a gear
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Why pharma must get smart in its approach to customer engagement
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- GSK appoint Tony Wood as chief scientific officer
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- PM announces plans to lift England’s COVID-19 restrictions
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Developing Innovative Digital Strategies to Engage Patients
- GSK appoint Tony Wood as chief scientific officer
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Cervical Cancer Prevention Month
- Why pharma must get smart in its approach to customer engagement
- Pfizer's 2021 revenue predictions soar to $82bn
- AZ’s PNH therapy Ultomiris wins EU backing to expand use for children
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- After the wildfire: how will healthcare recover from the pandemic?
- Paving the way for the HCP omnichannel experience: a guide for medical affairs
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
- Hybrid working: Insights and tips for success
- Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success...
